Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 2/20 | 0.65 |
| ▸ | GCGR | P47871 | 1/20 | 0.65 |
| ▸ | GIPR | P48546 | 1/20 | 0.65 |
| ▸ | VIPR1 | P32241 | 5/20 | 0.64 |
| ▸ | TFPI | P10646 | 1/20 | 0.63 |
| ▸ | VIPR2 | P41587 | 7/20 | 0.61 |
| ▸ | CCKBR | P32239 | 1/20 | 0.59 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.56 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30350066 | 0.94 | VIPR1 (0.65) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL31182595 | 0.94 | GLP1R (0.68) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL27043239 | 0.92 | TFPI (0.68) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL29416557 | 0.92 | TFPI (0.68) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL30726538 | 0.91 | GLP1R (0.58) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL29453341 | 0.91 | VIPR1 (0.72) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL29453357 | 0.91 | VIPR2 (0.70) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL30432341 | 0.91 | GLP1R (0.63) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL29496440 | 0.91 | VIPR1 (0.71) | GLP1RGCGRGIPRVIPR1TFPI | |
| SCHEMBL30038758 | 0.91 | VIPR1 (0.63) | GLP1RGCGRGIPRVIPR1TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066254-A | Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases | 阿德维塔生命科学有限责任公司 | 2022-09-16 | — | — | CN | disclosed |